Biocogniv
PrivateLast Round
VC Round
Oct 19, 2023
Total Funding Raised
$6.42M
Company Overview
Biocogniv is a digital diagnostics company that develops artificial intelligence-powered technology for acute care settings to predict time-critical medical conditions.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Healthcare Analytics, EHR & EMR
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biocogniv Comparables
Compare Biocogniv with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Clew | 86% | |
| Bayesian Health | 85% | |
| Prenosis | 85% | |
Biocogniv Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 19, 2023 | ||||
| Seed | Mar 16, 2022 | ||||
| Grant | Sep 1, 2020 | ||||
| Accelerator | Aug 25, 2020 |
Key People
Founding team and executive leadership
Biocogniv Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Breyer Capital | Seed |
| NIH RADx | Grant |
| Inflect Health | Seed |
| Promus Ventures | Seed |
| Y Combinator | Seed, Accelerator |
| 1984 Ventures | Seed |
Biocogniv Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biocogniv's valuation, stock price, and market status.